ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback